Skip to main content

Table 4 Correlation between POL η expression and clinicopathologic characteristics of gastric cancer patients

From: DNA polymeraseη protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy

characteristic POLη χ2 test
P value
Fisher's test
P value
  Positive
(n = 23)
Negative
(n = 57)
  
Age(y)     
   < 60 16 37 0.690 0.797
   ≥ 60 7 20   
Gender     
   Male 14 35 0.695 1.000
   Female 9 22   
Primary sites     
   Cardia 10 11 0.084 0.102
   Body 4 14   
   Antrum/pylorus 9 32   
Metastatic sites     
   Liver 11 15 0.247 0.269
   Lung 5 16   
   Peritoneum 3 16   
   Others 4 10   
Pathologic differentiation     
   G1 2 0 0.068 0.107
   G2 6 20   
   G3 15 37   
Treatment Response     
   CR+PR+SD 7 55 < 0.001 < 0.001
   PD 16 2   
  1. CR, complete response; PR, partial response; SD, stable disease; PD, progression disease.